AgeX Therapeutics Inc (FRA:0X40)
€ 17.44432 0 (0%) Market Cap: 25.61 Mil Enterprise Value: 29.32 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 36/100

AgeX Therapeutics Inc Pluripotent Stem Cells, Telomerase & Human Regeneration Transcript

Oct 27, 2020 / NTS GMT
Release Date Price: €47.83 (+3.03%)
James Ruhle
Simple Biotech - Moderator

Embryonic stem cell research offers both great promise and great peril, so I've decided we must proceed with great care.

What you just heard was George Bush, former President of the United States addressing the nation on live television about embryonic stem cells. This happened in 2001. And what prompted George Bush to address the nation on this particular day was the successful isolation of embryonic stem cells.

Now, although this discovery could potentially be one of the largest scientific achievements in all of human history, George Bush and his administration were afraid of the potential ethical and moral ramifications, something like this could represent for the United States and the human race as a whole. On that day, George Bush decided to effectively ban harvesting of any new embryonic stem cells. But to continue to allow any private company that already had possession of them to continue their research and to continue advancing the field.

The man, I interviewed he was the man behind the company that first isolated these embryonic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot